US 11,986,828 B2
Pathological slides and related systems and methods
Matthew O. Leavitt, Salt Lake City, UT (US); Mark S. Evans, Orem, UT (US); and Michael Andrew Ivie, Orem, UT (US)
Assigned to Leavitt Medical, Inc., Lehi, UT (US)
Filed by Leavitt Medical, Inc., Lehi, UT (US)
Filed on Oct. 30, 2019, as Appl. No. 16/668,169.
Claims priority of provisional application 62/753,917, filed on Nov. 1, 2018.
Prior Publication US 2020/0139361 A1, May 7, 2020
Int. Cl. B01L 3/00 (2006.01); G01N 1/30 (2006.01); G01N 1/31 (2006.01); G01N 35/00 (2006.01)
CPC B01L 3/508 (2013.01) [G01N 1/30 (2013.01); G01N 1/312 (2013.01); G01N 35/00029 (2013.01); B01L 2300/021 (2013.01); B01L 2300/022 (2013.01); B01L 2300/0822 (2013.01); B01L 2300/168 (2013.01)] 10 Claims
OG exemplary drawing
 
1. A pathology slide, comprising:
a substantially transparent substrate that includes a top major surface and a bottom major surface on an opposite side of the substantially transparent substrate from the top major surface;
at least two regions on the top major surface of the substantially transparent substrate, the at least two regions comprising at least two respective portions of the top major surface configured to receive at least two respective biopsy tissue sample sections on the substantially transparent substrate; and
at least one substantially straight separation mark comprising a void in the bottom major surface of the substantially transparent substrate, the at least one separation mark positioned between and separating the at least two regions from each other.